CTF Partners with Digital Science to Promote Open Data

Jan 23, 2018, Posted in Collaborations, Latest News, Science

The Children’s Tumor Foundation’s commitment to collaboration, open data and transparency is reinforced with a partnership with global technology company Digital Science on a new platform for next-generation research and discovery called Dimensions. This groundbreaking research information database aims to transform scholarly search by linking publications, grants, policy, data, and metrics for the first time.  

Children’s Tumor Foundation Launches I Know a Fighter 5K Tour

NEW YORK, NY – January 17, 2018 – The temperatures outside may still be in the single digits, but the Children’s Tumor Foundation is looking forward to warmer days ahead, with the announcement of an exciting new 5K race tour called the “I Know a Fighter 5K” to raise awareness and funds for the genetic disorder neurofibromatosis, or NF, which causes tumors to grow on nerves throughout the body. The I Know a Fighter 5Ks will take place in 10 cities across the United States starting this spring.

40th_Anniv_for_blog

40 Years of Fighting NF

Jan 9, 2018, Posted in Awareness, Community, Latest News

Over the past 40 years, there have been tremendous advancements in neurofibromatosis (NF) research, many of which can be traced back to research funded by the Children’s Tumor Foundation (CTF). From the very beginning, this Foundation was able to achieve a great deal for patients and families affected by NF.

New Webinar Series: Ask the Expert

Jan 8, 2018, Posted in Latest News, NF1, NF2, Schwannomatosis, Science, Video

We at CTF understand that not everyone living with NF is able to be seen by an NF expert on a regular basis or attend NF Forums, symposiums, or conference. With that in mind we are excited to bring you this webinar series!

journal

Children’s Tumor Foundation Funded Research Demonstrates Important Genotype-Phenotype Correlation in Neurofibromatosis

Research funded by the Children’s Tumor Foundation (CTF) and led by Ludwine Messiaen, PhD, professor of genetics at the University of Alabama at Birmingham (UAB), has shown that missense mutations in a cluster of just five codons in the NF1 gene are an important risk factor for severe symptoms of the genetic disorder neurofibromatosis (NF) type 1, thereby improving the predictability of this condition when these specific mutations are present in an individual. This work was published today in the American Journal of Human Genetics.

Next Page